Arotinolol Hydrochloride

DRUG2 trials

Sponsors

Sumitomo Pharma (Suzhou) Co., Ltd.

Conditions

Chronic Kidney DiseaseEssential Hypertension

Phase 4

Effect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis Patients

CompletedNCT01351636

Sumitomo Pharma (Suzhou) Co., Ltd.Chronic Kidney Disease

Start: 2011-04-30End: 2018-10-10Updated: 2019-04-17

Efficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart Rate

CompletedNCT02612298

Sumitomo Pharma (Suzhou) Co., Ltd.Essential Hypertension

Start: 2015-08-31End: 2018-09-13Updated: 2019-04-17